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Background: Upper limb impairment is a common problem for people with neurological
disabilities, affecting activity, performance, quality of life, and independence. Accurate,
timely assessments are required for effective rehabilitation, and development of novel
interventions. International consensus on upper limb assessment is needed to make
research findings more meaningful, provide a benchmark for quality in clinical practice,
more cost-effective neurorehabilitation and improved outcomes for neurological patients
undergoing rehabilitation.
Aim: To conduct a systematic review, as part of the output of a European COST Action,
to identify what recommendations are made for upper limb assessment.
Methods: We systematically reviewed published guidance on measures and protocols
for assessment of upper limb function in neurological rehabilitation via electronic
databases from January 2007–December 2017. Additional records were then identified
through other sources. Records were selected for inclusion based on scanning of titles,
abstracts and full text by two authors working independently, and a third author if
there was disagreement. Records were included if they referred to “rehabilitation” and
“assessment” or “measurement”. Reasons for exclusion were documented.
Results: From the initial 552 records identified (after duplicates were removed), 34
satisfied our criteria for inclusion, and only six recommended specific outcome measures
and /or protocols. Records were divided into National Guidelines and other practice
guidelines published in peer reviewed Journals. There was agreement that assessment
is critical, should be conducted early and at regular intervals and that there is a need for
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standardized measures. Assessments should be conducted by a healthcare professional
trained in using the measure and should encompass body function and structure, activity
and participation.
Conclusions: We present a comprehensive, critical, and original summary of current
recommendations. Defining a core set of measures and agreed protocols requires
international consensus between experts representing the diverse and multi-disciplinary
field of neurorehabilitation including clinical researchers and practitioners, rehabilitation
technology researchers, and commercial developers. Current lack of guidance may
hold-back progress in understanding function and recovery. Together with a Delphi
consensus study and an overview of systematic reviews of outcome measures it will
contribute to the development of international guidelines for upper limb assessment in
neurological conditions.
Keywords: practice guidelines, neurological conditions, upper limb, outcome and process assessment, systematic
review, guidelines, impairment, activity
INTRODUCTION
Worldwide prevalence of stroke in 2010 was 33 million, with
16.9 million people having a first stroke, of which 795,000 were
American and 1.1 million European (1). It has been estimated
that approximately one third of people fail to regain upper
limb capacity, despite receiving therapy (2). This has important
implications for both individuals and the wider society as reduced
upper limb function is associated with dependence and poor
quality of life for both patients and carers (3–5) and impacts on
national economies (6).
While stroke has the highest prevalence, other neurological
conditions such as Multiple Sclerosis (MS), Spinal Cord Injury
(SCI), and Traumatic Brian Injury, have a significant incidence
and there are often similarities in presentation, and treatment
and therefore assessment. The worldwide incidence of SCI is
40–80 cases per million population and the estimated European
mean annual rate of MS incidence is 4.3 cases per 100,000 (7).
Recently, Kister et al. (8) reported that 60% of people with
MS have impaired hand function. The impact of upper limb
dysfunction on ADL is higher than in stroke, as both sides are
often affected (9). Although dysfunction after SCI depends on
level of injury, upper limb function is consistently cited as a
health priority. The incidence rate of TBI in Europe is about
235 per 100,000 population (10). Outcome data among European
countries are very heterogeneous. From the US however, it is
known that about 1.1% of the population suffer a TBI resulting
in long term disability (11).
Rationale
Providing evidence-based and cost-effective upper limb
rehabilitation is a priority for patients and healthcare services
and is increasingly important because of the growth in
new technology-based interventions designed to augment
conventional occupational therapy and physical therapy.
Outcome data are key to delivering best practice and identifying
which interventions are effective. To design trials that will deliver
unequivocal results, so that useful, and only useful interventions
can be translated into clinical practice and delivered optimally,
we need to understand the complexity and interaction between
patient and intervention. To do that requires a large amount
of comparable data—i.e., data generated from an agreed small
set of valid outcome measures (OM) using agreed protocols. By
standardizing OM and protocols, aggregated data can be mined
to generate a better understanding of what interventions are
effective, at what dose, when, with whom and in what setting
they should be used. This will enable clinicians to make better
informed decisions and thus improve patient outcomes. Agreed,
widely used, valid and practical OMs and assessment protocols
are important in research into and treatment of all neurological
conditions, but may be particularly important in conditions
where incidence is lower and therefore data sets smaller.
Guidelines on best practice aim to improve treatment
standards, including rehabilitation, and directing future research.
And, as we argue above, OMs are key to achieving that goal. It
would seem reasonable therefore that clinical guidelines would
be a source of guidance on selection of OMs and protocols
for their use. In this study, we have therefore systematically
reviewed recent and current guidelines on stroke, MS, SCI, and
TBI. We have excluded all other neurological disabilities such
as Parkinson’s Disease and cerebellar ataxia as the assessment
protocols and tools for these conditions are very different. We
have extracted recommendations on assessment in terms of
outcome measures (OM), frequency of assessment and who
should conduct assessments, when and with what purpose.
Objectives
This study is one of three components in the development
of European Guidelines on assessment of the upper limb
in neurological conditions. Two studies have already been
published: A Delphi study which reported the views of experts
(12) and an overview of systematic reviews of OMs (13).
The project was driven by a realization that progress in
upper limb neurological rehabilitation research and consequently
improvement in quality of care was hampered by the absence
Frontiers in Neurology | www.frontiersin.org 2 June 2019 | Volume 10 | Article 567
Burridge et al. Systematic Review of Practice Guidelines
of consensus on OMs and protocols for assessment. To conduct
effective metanalysis requires multiple clinical studies to use the
same measures using comparable protocols, and for the same
OMs to be used in clinical practice. Practice guidelines are an
obvious source of information on useful measures and protocols
for assessment. The objective of this study was therefore to
explore published and web-based guidance and to extract
and synthesize recommendations on assessment measures and
protocols for assessment of upper limb function for people with
neurological conditions.
Research Question
Our research question was: What recommendations are made by
international clinical guidelines for the assessment of the upper
limb in neurological conditions?
METHODS
Study Design and Search Strategy
Published studies were identified through Pubmed and
Evidence Search databases (MEDLINE in Ovid, Embase,
CINAHL, AMED, Web of Science, PEDro and Google
Scholar) for the period from January 2007 to December
2017. The search strategy comprised the following medical
subject heading (MeSH) terms: stroke, multiple sclerosis,
spinal cord injuries and neurological rehabilitation with
filters for guidelines, recommendations, practice guidelines
and consensus development conference. The search was as
follows (((((“Stroke”[Mesh]) OR “Multiple Sclerosis”[Mesh])
OR “Spinal Cord Injuries”[Mesh]) OR “Traumatic Brain
Injury”[Mesh]) OR “Neurological Rehabilitation”[Mesh]))
AND (((Practice Guideline[pt] OR Recommendation OR
Guideline[pt] OR Consensus Development Conference[pt])) AND
(“2007/01/01”[PDat]: “2017/12/31”[PDat])). Using the search
engine Google, applying the terms “[nation],” guideline, “stroke,”
members of the COST action searched for their National Stroke
Guidelines in their respective languages: UK, Netherlands,
Italy, Spain, Germany, Switzerland, Sweden and Estonia. Using
the same terms, we also searched, in English for any other
National Guidelines from any country for stroke, SCI, MS,
TBI or Neurological Conditions. Additional records were also
identified through other sources, especially references from the
retrieved records.
Systematic Review Protocol and Data
Extraction
Two review authors (JB and AH) independently screened
references for relevance based on their abstract, and
methodological quality, where there were any disagreements
the wider group were consulted. Records were only included
in the review if they referred to upper limb “assessment” or
“measurement” and “physical rehabilitation” of “neurological
disorders” and were either a “National Guideline” or either
“practice guideline” or “recommendations” published in a
peer-reviewed Journal. Additional studies were identified
from references within the records and, where they satisfied
these criteria were included in the review. Although our
interest was primarily in upper limb assessment, the guideline
literature usually encompassed the broad topic of assessment,
i.e., both upper and lower limb, activities of daily living and
impact on quality of life. Such articles were screened, but
only included for further review when guidelines on upper
limb assessment were included. We did not use a standard
tool to assess quality. Records that satisfied the criteria for
inclusion were then categorized by two independent authors
(AH and JB) into: National guideline; other practice guidelines
or recommendations published in peer-reviewed journals or
web-based resources and then by condition into: stroke; multiple
sclerosis (MS); Spinal cord injury (SCI), traumatic brain injury
(TBI) or “other neurological conditions.” Each record was then
reviewed (LM, JB and AH). Data were then extracted from each
record and tabulated.
Data Analysis
Based on the review a classification structure (see below) was
designed to reflect the relevant areas in which recommendations
were made.
Classification structure:
1. Why assessment is important
2. When during the rehabilitation should assessment
be conducted
3. Clinical Utility—who should conduct the assessment
4. Single vs. multiple OMs within the ICF Framework
5. Assessment of body function and structures (impairment)
and activity
6. Assessment of Activities of Daily Living (ADL)
and participation
7. Psychometric properties and appropriateness of OMs
8. Self-Efficacy and goal orientated measures—assessment
integrated into therapy.
RESULTS
The records retrieved for the review and the results of the
selection process are shown in the flow diagram (Figure 1).
Study Selection Characteristics
Our primary aim was to review and synthesize recommendations
for the selection and use of upper limb OMs (both conventional
and technology-based) in neurorehabilitation. Our search
identified no records that focussed exclusively on the UL and
the majority made only brief reference to either assessment
or measurement tools (14–18). Where reference was made to
measurement there was explicit consensus that measures should
follow the World Health Organization (WHO) International
Classification of Function (ICF) framework (19, 20).
Synthesized Findings
Of the 34 publications included in the review only six (two
National Guidelines)
recommended specific measures of body function and
structures, activity and participation (14, 15, 17, 18, 21, 22). Seven
recommended global scales but gave no specific measures for
the upper limb (23–28). Most National Guidelines focussed on
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FIGURE 1 | Flow diagram of the studies retrieved for the review.
service delivery. Some acknowledged that standardized OMs are
required for effective neurorehabilitation, without reference to
specific tools or how they should be chosen. The need for OMs
that encompass all domains of the ICF was agreed.
Nine publications referred to the importance of global
or upper limb assessments being conducted by appropriately
trained or qualified healthcare professionals (HCP) (22, 29–36).
Protocols for and timing of assessment was only included in four
records (17, 21, 22, 37). In total, reviews identified 47 different
global and upper limb specific OMs, but only one referred
to effectiveness, validity or reliability of the recommended
measures (17).
Fourteen National Guidelines were included in the review
(Table 1) from the following countries: The Netherlands,
Sweden, UK (4), Scotland (2), Estonia, South Africa, Singapore,
Australia, New Zealand and the USA. National guidelines were
condition specific: 11 stroke, 1 brain injury, 1 SCI and 1MS.
National Guidelines provided themost comprehensive and broad
recommendations. All National stroke guidelines except the
South African (33) and Swedish (55) make some reference to
assessment, but in almost all cases it was brief, non-specific and
not related either to rehabilitation or the UL. There were two
exceptions to this.
The Dutch National guideline (17), provided very
comprehensive recommendations on the diagnostic process
and included recommendations for specific tools, within each
ICF domain, that should be used for diagnosis—to allow
informed clinical decision-making; to predict recovery and to
assess progress. Recommendations are summarized as follows:
Any patient with a stroke should be systematically assessed
in terms of body functions, activities, and participation prior
to the start of the physical therapy process, preferably using
reliable, valid, and responsive measurement instruments.
These measurements should be administered at predefined
moments during the physical therapy process, in order to
objectively monitor the patient’s clinical course. Basic upper limb
measurement should include: muscle strength, dexterity and
ADL. Tools were selected by the guideline development team
on the basis of their reliability, responsiveness, predictive and
construct validity, and finally their practical feasibility. They
make recommendation for future practice: “many publications
fail to report follow-up data, and if they do, the timing of follow-up
assessments varies widely. This means that the long-term added
value of nearly all interventions is unknown.” It is suggested that
“frequent and systematic assessment of functional changes over
time (monitoring)” is an important factor contributing to higher
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TABLE 1 | Summary of the National Guideline records included in the review.
Record Year Summary of recommendations Recommended measures
Australian Stroke Foundation (38).
(Stroke)
2017 Use of valid measures; assessment made by trained
clinicians. No reference to physical assessment of
the upper limb
None
Winsteinet al. (14) (Stroke) 2016 Recommends a single assessment used throughout
the course of stroke recovery
Computerized questionnaire: “Activity Measure for
Post-Acute Care”; dynamometer (grip strength) (39);
electro-goniometer (range of motion) (40) and Frey
filaments (tactile sensory deficits) (41). Fugl-Meyer (42)
and Box and Block Test (43)
Royal College of Physicians (16)
(Stroke)
2016 Use of the WHO ICF and instruments appropriate to
the intervention. Clinicians should be trained in the
use of measurement scales; set agreed goals
(including patient and carers)
None
Veerbeek et al. Dutch Guidelines (17)
(Stroke)
2014 Measures that are valid, reliable, responsive and
feasible within each ICF domain. Use for diagnosis,
clinical decision-making, to predict recovery, and
assess progress.
Measure at predefined times to monitor recovery
e.g., within one week of admission and discharge
(or when transferring care) end of the 1st week, 3rd
and 6th month post-stroke. Consider measures
before each multidisciplinary meeting.
Motricity Index (44); Fugl-Meyer (FMA UE) (42) Frenchay
Arm Test [FAT]) (45), Action Research Arm Test (ARAT)
(46) and Nine Hole Peg Test (NHPT) (43). MAS (47);
Nottingham Extended ADL (48); Global measures:
SSQoL (49); Barthel Index (50), NIHSS (51)
NICE, Multiple Sclerosis (32). (MS) 2014 No reference to upper limb problems.
Assessment should be conducted by a “healthcare
professional with appropriate expertise in
rehabilitation and MS”.
None
SIGN. Guideline 130 Brain injury
rehabilitation in adults (26) (TBI)
2013 Brief reference to assessment and OM: “A range of
tools can assist in the assessment and setting of
goals”; no specific recommendations on measures
or timing.
COPM (52), FIM/FAM (53), Barthel Index (50).
NICE. Stroke rehabilitation in adults -
NICE guideline (28) (Stroke)
2013 Screen for impairment, activity limitations,
participation restrictions, and environmental factors
to direct treatment on admission and on transfer
from hospital to community.
Standardized valid and reliable screening
instruments should be used by HCPs who have
appropriate skills and training. Wrist and hand
splints should be assessed and fitted by trained
HCPs. In research, the primary outcome measure
should be improvement in function, with secondary
outcomes assessing impairment, function, and
quality of life.
NIHSS (51); Barthel Index (50)
NSCISB. The National Spinal Cord
Injury Strategy Board (54). (SCI)
2012 Only reference to rehabilitation is passive movement
to maintain joint range with no reference to
assessment.
None
Bryer et al. The South African
guideline (33) (Stroke)
2011 Early assessment and planning of discharge and
comprehensive assessment of medical problems,
impairments and disabilities by specialist staff is
needed.
None
Swedish National Board of_Health
and Welfare. Quality and efficiency of
stroke care in Sweden (55). (Stroke)
2011 No recommendations for OM. None recommended
Venketasubramanian et al. Singapore
Clinical Practice Guidelines
Workgroup on Stroke (56) (Stroke)
2011 Recommends multi-disciplinary medical
assessment in acute stroke or transient ischemic
attack (TIA). No reference to UE assessment
None
Guideline 118. SIGN. Management of
patients with stroke (57). (Stroke)
2011 Assessment of patient’s needs to set goals and
re-assess progress against goals. No reference to
UE assessment
None
Estonian clinical guidelines for stroke
rehabilitation (27) (Stroke)
2011 Use of valid and standardized measures including
assessment of sensorimotor function, cognition,
speech, and ADL in predefined time points.
NIHSS (51), FIM (53), Barthel Index (50), Modified
Ashworth Scale (58); Berg Balance Test (59)
New Zealand Clinical guidelines for
Stroke Management (60). (Stroke)
2010 Reference to assessment in acute care and of those
who want to return to work.
None
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quality of care. They recommend considering measures before
each multidisciplinary meeting.
The US National Guideline (14) also makes comprehensive
recommendations on assessment for best clinical practice. It
acknowledges the need for a single assessment used throughout
the course of stroke recovery, referring to measures of body
function/structure and citing the upper limb motor section
of the Fugl-Meyer scale or the Box and Block Test for
measuring arm motor deficits. The Australian Guideline (38),
focuses on interventions, but recommends assessment using valid
measures, although without reference to physical assessment
of the upper limb. The New Zealand (60) guideline makes
recommendations on all aspects of stroke management and
prevention based on level of evidence, expert opinion and
clinical experience, however, the only reference to assessment
is in relation to acute care and of people who want to return
to work.
Six UK Guidelines (of which two were Scottish) were found:
three for Stroke (16, 28, 61), one for SCI (54), one for brain
injury (62), and one for MS (32). The Royal College of Physicians
(RCP) stroke Guideline is a comprehensive guideline for best
clinical practice. The RCP Guideline considered the general
principles of measurement in stroke rehabilitation, for example
the importance of measuring function and understanding
which domain of the WHO ICF framework an instrument is
measuring. It states that instruments should be appropriate to
the intervention in question and clinicians should be trained in
the use of measurement scales to ensure consistent use within
the team. The National Institute of Clinical Excellence (NICE)
recommendations (28) guidelines were mainly concerned with
the organization of health and social care and specifically
the delivery of best practice. Specific recommendations were:
screening on admission and on transfer from hospital to
community using the WHO ICF to provide information on
functional abilities; use of standardized screening instruments;
treatment and assessment should be provided by HCPs who have
appropriate skills and training and patients should be assessed
and fitted for wrist and hand splints by trained HCPs. The third
UK guideline onMSmakes no reference to upper limb problems,
however does specify that assessments should be conducted
by a “healthcare professional with appropriate expertise in
rehabilitation and MS.” The fourth UK Guideline, on SCI (63)
also makes no reference to upper limb assessment, focusing only
on medical assessment except for brief reference to the need for
a musculoskeletal assessment including spasticity, joint range of
movement, and pain. Neither the Singapore (56) nor the Swedish
(55) Guidelines make recommendations on assessment. The
Singapore Guidelines 1(56) state the importance of assessment
in acute stroke, giving recommendations, but make no reference
to assessment in rehabilitation. Although not an official National
publication, we have included the Canadian Web-based Stroke
Rehabilitation Evidence-Based Review SREBR guidelines1 which
provide comprehensive recommendations on assessment and
present level of evidence for a wide range of clinical scales. The
SREBR consolidates the best available scientific evidence for the
1(http://www.ebrsr.com/)
effectiveness of stroke rehabilitation and is an excellent resource.
The review is constantly updated and includes a substantial
section on OMs. The SREBR used the ICF Framework and in
addition to the usual measures of reliability and validity, also
considered appropriateness and responsiveness (floor and ceiling
effects), precision, interpretability, acceptability, feasibility, and
the thoroughness of testing. The scope is very wide, including
tests for cognition, depression etc. It does not address upper
limb assessments per se, but includes a number of UL
focussed impairment and activity measures, which are scored in
each category.
Nineteen other articles were included in the review (Table 2).
Peer review articles were generally less comprehensive than
the National Guidelines and often focused on a specific
area of neurological rehabilitation, for example Occupational
Therapy or tele-rehabilitation. They were however more focused
on upper limb OMs and some gave recommendations for
specific measures.
In total, 51 outcome measures were recommended, of which
39 addressed stroke (76%), 5 TBI (10%), 3 SCI (6%), 1MS
(2%). Four outcome measures (8%) were recommended without
specifying which pathology it should be used for. Regarding
stroke guidelines, the most frequently recommended OMs were
NIHSS (5), FIM (4), Barthel Index (3), and FMA (3). For the
other pathologies, recommended OMs were scattered across
different OMs.
We have synthesized recommendations made by the National
Guidelines and published articles under the following headings:
Why, when and by whom assessments should be conducted and
what should be measured.
Why Assessment Is Important
“Not Everything That Counts Can Be Counted” (81) but without
valid, reliable and sensitive measures that are meaningful to
patients, clinicians and researchers our field cannot advance. We
will not know what works, when or with whom. Neurological
rehabilitation is complex in terms of both patients and
intervention (26, 57) There are few interventions or conditions
for which there is a single measure as there is for example in
testing a new drug for hypertension. Winstein (14) acknowledges
the challenge faced in assessing services, patient outcomes and
effectiveness of neurological rehabilitation stating that: “the
array of rehabilitation services delivered to stroke patients in
the United States is broad and highly heterogeneous, varying in
the type of care settings used; in the duration, intensity, and
type of interventions delivered.” and that this “brings with it
challenges in terms of determining the quality of care delivered
by the system” and “in terms of assessment of which research
findings. . . are applicable to the system.” Alexander (78) identified
the need for agreed measures in their multi-disciplinary study
of current and evolving tools for evaluating people with spinal
cord Injury (SCI), reporting that none of the findings of
major clinical trials of new interventions had translated into
standard care and argued that to achieve translation, “agreed,
appropriate and valid primary end points and intervention
protocols are needed.”
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TABLE 2 | Summary of the peer reviewed and practice guideline records included in the review.
Record Year Summary of recommendations Recommended measures
Wechesler et al. (23) (Stroke) 2017 Improve quality monitoring and outcomes and
consider sharing patient data. NIHSS score done
remotely during transit to hospital (64)
NIHSS score (51)
Intitut National d’excellence en sante et en
sociaux—(TBI)
2017 Guidance on global assessment and rehabilitation
interventions including motor control. No specific
reference to, or recommendation for UE assessment
None
ATAXIA UK. Ataxia UK (24) (Non-specific
pathology)
2016 No reference to UE specifically. Measure patient
engagement and satisfaction with the performance of
an activity,
Assessment of Motor and Process Skills (AMPS) (65),
Goal Attainment Scale (GAS) (66), Canadian
Occupational Performance Measure (COPM) (52),
self-efficacy tools and quality of life measures.
Wolf et al. (67) (Stroke) 2015 No recommendations for assessment None
Hebert et al. Canadian stroke best
practice recommendations (37) (Stroke)
2015 Assessment within 48 h including: function, safety,
physical readiness, and ability to learn and participate
in rehabilitation. No specific reference to UE
None
Majersik et al. (25) (Stroke) 2015 Studies exploring genetic factors should also measure
stroke outcomes. Medical and global outcomes,
impairment and activity early post stroke, at 3 months
and ideally at 6 and 12-months’ post stroke.
Document access to and amount of therapy
No specific upper limb measures.
NIHSS (51), GAS (66), FIM (53)
Haselkorn (68) (Stroke) 2015 No specific recommendations None
College of Occupational Therapists and
Association Of Chartered Physiotherapists
in Neurology. (15). (Splinting. Non-specific
pathology)
2015 Use valid and reliable measures across the ICF
framework. Global measures are unlikely to be
sensitive to changes, but should be included; choice
and timing of OM is important. Recommendations for
future research include use, choice and timing of OM
Arm activity measure (69)
Visual analog scale (70); ARAT (46)
Potter et al. (71). (MS) 2014 Important to consider measures that can be used in
different settings (hospital vs. home) to track patients
over a long period
No specific recommendations
Billinger et al. (72). (Stroke) 2014 No specific OM for UL None
Finlay and Evans (metastatic spinal cord
compression). (21) (SCI)
2014 Pain, motor and sensory dysfunction assessment
should be carried out within 24–48 h of admission and
prior to discharge. Pain should be re-assessed at least
daily. Only when the MSCC is deemed stable or more
active rehab is permitted can the full assessment be
completed. A wide range of measures can be obtained
through: http://www.rehabmeasures.org/default.aspx
Light touch sensation; Sharp/blunt or pin prick
sensation; Joint proprioception; Muscle power (myotome
chart and Oxford classification); Muscle tone: flaccidity or
spasticity (MAS) (58); Joint ROM (active/passive) and
muscle length; Personal activities of Daily Living (PADL):
Activities of Daily Living (ADL):
Ontaneda et al. (MS) (73). (MS) 2012 A universally accepted measurement instrument that is
precise, reliable, easy to administer, captures key
neurological domains affected by MS, is sensitive at all
levels of disability and accurately reflects neurological
and neuropsychological disability is still lacking.
Agreeing on single clinical measure that is useful at all
stages of the disease is challenging
Multiple Sclerosis Functional Composite (MSFC)
approach.
Recommends the development of a database focused
on MSFC and follow-up projects aimed at developing
patient-reported outcomes, imaging markers, and
biological markers of the MS disease process.
Canadian EBRSR (http://www.ebrsr.com/)
(18) (Stroke)
2012 Use of the ICF Framework; reference to reliability,
validity, appropriateness and responsiveness (floor and
ceiling effects), precision, interpretability, acceptability,
feasibility. Does not address UE assessments per se,
but includes a number of UE focussed impairment and
activity measures, which are scored in each category.
Provides information for selection of most appropriate
measure.
Impairment: FMA (69), and MAS (47, 74)
Activity: ARAT (46), B&B (43), Chedoke-McMaster (75),
FIM (53), 9HPT (43, 76), WMFT (77)
Participation: COPM (52)
Miller et al. (34). (Stroke) 2010
Hypertonicity should be assessed, but no
recommended tools. The MAS has poor validity and
inter-rater reliability. Other measures have not been
shown to be feasible clinically.
Acknowledges importance of trained assessors.
Recommends ADL Assessment post-discharge from
rehabilitation
15 Upper Limb Motor assessments are listed as
‘commonly used’
(Continued)
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TABLE 2 | Continued
Record Year Summary of recommendations Recommended measures
Tools should be agreed by the MDT and be valid and
reliable.
No reference to UE
Hachinski et al. (35). (Stroke) 2010 Calls for consensus on, then implementation of,
standardized clinical and surrogate assessments. No
reference to UL
Tools for measuring the biology of stroke recovery are
needed to inform optimal timing, intensity, duration,
and content of therapy.
The best standardized measures of behavior and
outcomes after stroke need to be defined and used in
clinical practice. Standardized rater training needs to
be developed. Surrogate markers of treatment effect
could also be used as predictive tools for outcome and
thus be of value for entry criteria in clinical trials or in
evaluating treatment outcomes and guide clinical
decision-making.
No specific reference to UL assessment.
None
VA/DOD The Management of Stroke
Rehabilitation (22) (Stroke)
2010 NIHSS performed by trained, certified assessors within
the first 24 h, and consider re-assessing prior to
discharge from acute care.
Motor function assessed at impairment and activity
levels using assessments with established
psychometric properties.
A standardized assessment tool should be used to
assess ADL/IADL
A MDT assessment should be undertaken to establish
the patient’s rehabilitation needs and goals.
Functional Independence Measure (FIM) (53). NIHSS (51)
Motor function: muscle strength for all muscle groups,
active and passive range of motion, muscle tone, ability
to isolate the movements of one joint from another, gross
and fine motor co-ordination.
The daily use of the paretic extremity should be
assessed using a self-report measure (e.g., the Motor
Activity Log) (47) and accelerometery.
Alexander et al. (78) (SCI): 2009 Evaluation of UE impairment is important, but generic
tests of hand function are ill-suited for use with
persons with SCI, with the exception of the Grasp and
Release test - developed to assess the effect of a
neuroprosthesis.
Grasp and release test (79)
Gall et al. (63) (SCI). 2008 No reference to upper limb assessment, except for
brief general mention of spasticity, joint range of
movement, and pain assessment
None
Steeves et al. (80). (SCI) 2007 Recommends assessment of UE function, including
sensation in clinical trials and acknowledges lack of
agreement and absence of SCI specific tests for SCI
and lack of sensitivity in current measures. Discusses a
range of tools without giving specific recommendations
Accurate sensitive and functional measures
Bayley et al., ABIKUS (36) (TBI). 2007 Recommendations based on a systematic review.
Recommends assessment of spasticity and motor
function by trained professionals
None
When During the Rehabilitation Period Should
Assessments be Conducted?
Nine publications (seven stroke) referred to timing of
assessments in relation to rehabilitation recommending
soon after admission and on transfer of care. Beyond that there
was wide variation, particularly in frequency of assessments.
The Dutch Guidelines recommended that patients were
assessed within 1 week of admission and discharge (or
when transferring treatment to another colleague) and at
the end of the 1st week, 3rd and 6th month post-stroke.
They also recommended considering measures before each
multidisciplinary meeting. The NZ guidelines stated that
patients should be assessed when treatment choices were being
made, as assessments were fundamental to measuring deficits,
planning goals, and planning management. It recommended
that all assessments occurred as soon as possible after admission
(aiming for within the first 2 days) with the stroke team
working together so as not to overburden the patient by
duplicating questions.
The COT and ACPIN Report (82) was concerned with
splinting and suggested that specified outcomes should
be recorded at baseline and at defined intervals, but they
did not suggest what these should be (25). Winstein (14),
recommends that “all patients should undergo a formal
assessment of their rehabilitation needs before discharge” and
Finlay (21) recommend that physiotherapy assessments
be carried out within 24–48 h of admission and that the
assessment should include pre-admission mobility and motor
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dysfunction. The Canadian best practice guidelines state initial
screening and assessment should be conducted within 48 h by
rehabilitation professionals.
There were only two publications which referenced timing
of assessment in MS and SCI, The American Physical Therapy
Association Neurology Section task force recommended using
OM to track MS patient status over a long-term period or
as patients transition across settings (71). The Guidelines and
Audit Implementation Network (GAIN) recommends PT and
OT therapy assessments (pain, motor and sensory dysfunction)
for SCI should be carried out within 24–48 h of admission and
prior to discharge.
Clinical Utility—Who Should Conduct the
Assessment
A strong consensus was found in favor of assessments
being conducted by appropriately trained HCPs. Patients with
difficulties in performance of daily activities should be assessed
by a clinician trained in the use of whichever scales are chosen
to ensure consistency of their use within the team and an
understanding of their purposes and limitations (60). This view is
supported by (34) recommending that clinicians obtain not only
training to establish administration and scoring consistency, but
also, routine retraining to ensure they maintain this consistency
(71). They highlight the fact that although OMs have benefits in
physical therapist practice multiple barriers interfere with their
use, most notably, a limited understanding of how to select and
apply the best OM.
Single vs. Multiple and Specific OMs, Within the ICF
Framework
No records recommended a single OM with the exception
of Winstein (14) who suggested the use of a computerized
questionnaire called the “Activity Measure for Post-Acute Care”
as an outcome measure for all stroke patients to “track
stroke rehabilitation outcome.” Billinger (72) suggested that
accelerometery was likely to be used as an OM for future clinical
trials as it measured changes in free-living physical activity and
compliance with exercise programmes.
There was consensus between the Dutch, UK, and US
guidelines that patients should be assessed in each domain
of the ICF framework, but conflict between using a single
measure to enable progress to be monitored throughout recovery
and multiple measures to allow for changes in setting, goals
and ability levels. The US guidelines recommend multiple
OMs whereas the most recent stroke guidelines from the
UK National Institute for Health and Care Excellence (NICE)
(28) recommend primary and secondary OMs, with the
primary assessing function and secondary including measures of
impairment, activity limitation and quality of life. The Scottish
Intercollegiate Guidelines Network (26) recommended using a
range of assessment tools to assist goal-setting. Multiple OMs
were often recommended (14, 15, 17, 21, 71) arguing, for
example, that it would be challenging to select only 1 or 2
OMs for use with all people with Motor Neurone Disease
(MD) and Multiple Sclerosis (MS) (83, 84) due to variation
in disability levels and treatment in a variety of settings.
Ontaneda (73) concurred, recommending different OMs for
people at different stages of MS and the RCOT (85) agreed
with (71) that a “one size fits all” intervention with a single
outcome measure was of limited, if any, value. The SIGN TBI
guideline (26) stated that because rehabilitation interventions
usually target multiple or complex outcomes, and because
individual goals vary, a single measure may be impossible
or inappropriate.
Assessment of Body Function and Structures
(Impairment)
The US Guidelines were skeptical about the use of measures in
the body structure and function (impairment) domain of the ICF
framework, considering that the psychometric properties of tools
had not been established. They referred specifically to measures
of spasticity/hypertonicity citing the equivocal evidence for
validity and inter-rater reliability for the Modified Ashworth
Scale. The VA/DOD Guidelines (22) however, made very strong
and clear recommendations for measuring motor function both
at the impairment (ability to move in a coordinated manner in
designated patterns) and at the activity level (performance in real
life or simulated real life tasks) using assessments with established
psychometric properties.
In terms of measuring spasticity, Miller et al. (34)
acknowledged the problem of validity and interrater reliability
of the most commonly used Modified Ashworth Scale, but
that other spasticity measures reported in the literature have
problems with respect to clinical feasibility and the range of
joints that could be assessed. Alexander (78) was one of the few
to discuss the use of electrophysiological measurements such
as Electromyography (EMG), Motor Evoked Potentials (MEPs)
and Somatosensory Evoked Potentials (SEPs) to assess spinal
conductivity and spasticity in SCI. Hachinski (35) was one of
the few records to refer to the need for assessments to measure
the mechanisms of recovery. It reported the consensus of a
“Synergium,” commissioned to finding new ways of accelerating
progress in reducing the risks, effects, and consequences
of stroke.
Assessment of Activities of Daily Living (ADL) and
Participation
While upper limb function has a significant impact on ADL, QoL
and participation, it is beyond the scope of this review to consider
in detail the recommendations for OMs in these categories,
especially as they do not specifically assess the upper limb. The
Dutch guidelines, however, proposed a range of measures to
assess factors that may impact on recovery of UL function and
therefore ability to participate in everyday life (17).
Psychometric Properties and Appropriateness
of OMs
The Australian Guidelines recommended that Clinicians use
tools that meet the needs of the patient and are valid and
reliable in the stroke population. The NZ guidelines added
that while, because of the enormous variety of assessment tools
and measures, they did not make specific recommendations, it
was important to choose a specific tool based on the validity
Frontiers in Neurology | www.frontiersin.org 9 June 2019 | Volume 10 | Article 567
Burridge et al. Systematic Review of Practice Guidelines
(in a stroke population), reliability, and availability. Miller (34)
recommended standardized, valid and reliable test procedures
to document the severity of upper and lower limb impairment
and to document the levels of assistance needed for mobility.
Alexander (78) emphasized the importance of using measures
that were valid, reliable and sensitive in the SCI population and
concluded that further work was needed on existing measures
to identify the most appropriate tools for specific targets.
Finlay (21) directed the reader to The Rehabilitation Measures
Databases2 both of which provide information on a wide range of
useful assessments and OMs. These are excellent repositories of
measures, providing information on conditions where theymight
be used, availability, time taken to complete the tests, training
required to conduct them and links to references, some of which
include data on psychometric properties. They do not, however,
make recommendations per se.
Self-Efficacy and Goal Orientated
Measures—Assessment Integrated Into Therapy
The RCP (16) recommended that people with stroke should be
helped to identify goals with specific, time-bound andmeasurable
outcomes, but does not recommend specific measurement tools
to assess whether goals have been achieved. There is a clear
distinction between measuring what a person “can do” and
what they “do do.” Many of the standardized, recommended
and commonly used measures of impairment and activity
do not address the latter, whereas Patient Reported Outcome
Measures (PROMs) and measures of self-efficacy, focus on
what the patient actually does (or reports doing) in their day-
to-day life. In relation to this, Ataxia UK (24), stated that
OMs should focus on engagement and satisfaction because a
tool that measures impairment does not always demonstrate
effectiveness. The Management of Stroke Rehabilitation Report
(22) recommended both a self-report measure (e.g., the Motor
Activity Log) and an objective measure (e.g., accelerometry)
to assess daily use of the affected upper limb and also as a
motivational or self-management tool for participants taking part
in clinical trials (72). Despite these recommendations, the review
of OMs used in (neurorehabilitation) limb splinting evaluation
studies, conducted by the Royal College of Occupational Therapy
(RCOT) and Association of Physiotherapists in Neurology
(ACPIN), found that patient satisfaction was the least common
OM used (82).
Risk of Bias
Data sources were predominantly English language, which may
have biased the main findings. However, in mitigation, as
authors, who were members of the COST Action, covered
several languages we were able to search for (and include)
National Stroke Guidelines in a range of languages. Differences
in health care systems worldwide may also have been a
source of bias reflected in the recommendations made in the
primary publications.
2http://www.rehabmeasures.org/default.aspx and http://www.neuropt.org/
professional-resources/neurology-section-outcome-measures-recommendations
Finally, the quality of identified guidelines was not evaluated
with a standard tool such as AGREE II (Appraisal of Guidelines
for REsearch and Evaluation). AGREE generates summary
scores, in which all items and domains have equal weight.
This tool is useful in judging the quality of the Guidelines
and was used in Jolliffe et al.’s recent systematic review
of Clinical Guidelines for Stroke and other Acquired Brain
Injuries (86). However, their aim was to identify high quality
guidelines, whereas ours was more specific; to “identify what
recommendations are made for upper limb assessment.” Instead
we therefore used descriptive analysis to identify evidence-based
consensus on upper limb assessment across multiple pathologies
to generate an in-depth knowledge of the quality and content of
each guideline.
DISCUSSION
Summary of Main Findings
Our review of National Guidelines and published articles on
recommendations for OMs in UL rehabilitation following Stroke,
MS, SCI, and other neurological conditions has identified
some areas in which there is a clear consensus. For example,
that assessment is important in neurological rehabilitation,
should encompass all domains of ICF Framework and that,
with one exception, multiple OMs should be used. Where
recommendations included protocols for use of OMs, there was
no disagreement to the following: they should be applied byHCPs
who are trained to use them and at regular intervals during the
rehabilitation pathway. Although intervals vary, global measures
are recommended within 24 h of admission and UL specific
measures within 1 week. All published articles and Guidelines
recommend early assessment and assessment prior to discharge,
while many recommend far more frequent assessments. The
importance of linking assessment to goal-setting (24, 57, 61), the
use of measures to encourage andmotivate patients (24) as well as
the importance of patient reported outcome measures (PROMS)
(22) was evident. These recommendations reflected recognition
of the importance of self-efficacy and independence and PROMS
to assess what a patient actually does rather than can do is
important. What we found lacking was recommendation to use
specific outcome measures for which validity and reliability have
been demonstrated. There was also lack of consensus on which
measures should be used; although there was more agreement
about global measures of participation and ADL than UL specific
measures of impairment and activity limitation. The FIM for
example is recommended in six reviews.
There was very little agreement across the Guidelines about
what outcome measures should be used, even within pathologies
and the categories of the ICF (Table 3). Even regarding the
condition for which the majority of OM recommendations were
made (76%), stroke, guidelines fail to agree on a specific set of
OMs to be used. The most frequently recommended OMs in
stroke guidelines were three global stroke OMs (NIHSS, FIM,
Barthel Index) and only 1 specific upper limbOM (FMA). Two of
those regarded OMs on Activity level (global), NIHSS, and FIM,
between which no consensus was apparent either.
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TABLE 3 | Frequency with which different outcome measures were recommended in total and for each pathology included in the review.
Domain Outcome measures Total number of records/References Number of records per pathology
Stroke MS SCI TBI Other
Impairment Fugl-Mayer Assessment (FMA) 3 (14, 17, 18) 3 0 0 0 0
Modified Ashworth Scale (MAS) 2 (17, 21) 1 0 1 0 0
Muscle power (Myotome chart and Oxford
grading)
1 (21) 0 0 1 0 0
Passive Range of motion 2 (21, 22) 1 0 1 0 0
Electro-goniometer (range of motion) 1 (14) 1 0 0 0 0
Grip strength (e.g. Jamar dynamometer) 1 (14) 1 0 0 0 0
Co-ordination and selective muscle activity 1 (22) 1 0 0 0 0
Grasp and release test 1 (78) 0 0 1 0 0
Box and Block test (BBT) 1 (14) 1 0 0 0 0
Nine-hole-peg-test (9HPT) 2 (17, 18) 2 0 0 0 0
Motricity Index (MI) 1 (17) 1 0 0 0 0
Impairment (Sensation
and Pain)
Visual Analog Scale (VAS) 1 (15) 1 0 0 0 0
Light touch 1 (21) 0 0 1 0 0
von-Frey filaments 1 (14) 1 0 0 0 0
Proprioception 1 (21) 0 0 1 0 0
Activity (UL) Wolf Motor Function Test (WMFT) 1 (18) 1 0 0 0 0
Assessment of Motor Processes and Skills
(AMPS)
1 (24) 0 0 0 0 1
Arm Activity Measure 1 (15) 0 0 0 0 1
Action Research Arm Test (ARAT) 3 (15, 17, 18) 2 0 0 0 1
Chedoke McMaster 1 (18) 1 0 0 0 0
Computerized questionnaire 1 (14) 1 0 0 0 0
Frenchay Arm test (FAT) 1 (17) 1 0 0 0 0
Activity (Global) National Institute of Health Stroke Scale
(NIHSS)
5 (17, 22, 25, 27, 28) 5 0 0 0 0
Canadian Occupational Performance
Measure (COPM)
1 (62) 1 0 0 1 0
Goal Attainment Scale (GAS) 2 (24, 25) 1 0 0 0 1
Functional Independence Measure (FIM) 5 (18, 22, 25–27) 4 0 0 1 0
Multiple Sclerosis Functional Composite
(MSFC)
1 (73) 0 1 0 0 0
Motor Activity Log (MAL) 1 (22) 1 0 0 0 0
Berg Balance Scale (BBS) 1 (27) 1 0 0 0 0
Participation and QoL Barthel Index (BI) 4 (17, 26–28) 3 0 0 1 0
Personal Activities of Daily Living (PADL) 1 (21) 0 0 0 1 0
Nottingham Extended ADL 1 (17) 1 0 0 0 0
Stroke Specific Quality of Life Scale
(SSQoL)
1 (17) 1 0 0 0 0
Total = 52 39 1 3 5 4
Without an internationally agreed core set of outcome
measures that satisfy the requirements identified in this review,
progress in neurorehabilitation will remain hampered and data
will be wasted. From the research perspective, it is well-known
that clinical trials of conventional and novel interventions
are expensive, often return equivocal results and frequently
fail to recruit adequate samples of patients. An important
way that we can advance the field of neurorehabilitation,
gain a better understanding of the recovery processes and
disease progression and understand what works, with whom,
when and in what dose is through meta-analysis of multiple
trials, audits and longitudinal studies. Meta-analysis can only
be done effectively if common outcome measures have been
applied. Lack of meta-analyses impacts not only research into
effectiveness of existing and novel therapies but also in delivering
best practice.
National strategies and frameworks continue to emphasize
the need for informed decision making in healthcare that are
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research led and evidence-based, yet the UK, Australian and
US National Clinical Guidelines for Stroke indicate that there is
limited research to assess efficacy of rehabilitation technologies,
either individually or in combination (14, 16, 31).
Limitations
This systematic review has explored “National Guidelines,” or
“practice guidelines,” and “recommendations” published in peer-
reviewed journals, focusing on assessment of the UL. We did
not generate quantitative data, conduct a statistical analysis or
use a standardized tool to assess the quality of the publications
(see section on risk Bias above). We included all guidelines that
satisfied our criteria and have not provided critical analysis of the
quality of each publication.
CONCLUSION
Clinical practice guidelines provide very little specific guidance
on assessment of the UL, even within ICF domains and/or
pathology-specific recommendations. Agreement on a core set
of OMs is not achieved by systematic reviews of guidelines
such as this, predominantly due to a lack of explicit OM
recommendations in most of the identified guides. Nevertheless,
our extensive and rigorous review has provided a comprehensive
summary of current recommendations, and therefore arguably
current use of OMs. Defining a core set of measures and
agreed protocols requires international consensus between
experts representing the diverse and multi-disciplinary field of
neurorehabilitation. The group should include representation
from research and clinical practitioners as well as rehabilitation
technology researchers and commercial developers, so that
recommendations are made cognoscente of the future potential
for technology in assessment and neurorehabilitation. If
such a consensus was achieved, a standardized approach to
assessment would make research findings more meaningful
and provide a benchmark for quality in clinical practice
and potentially improved standards and more cost-effective
neurorehabilitation. Our review has identified agreement that
assessment is critical and should encompass body function and
structure, activity and participation and that there is a need for
standardized measures.
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